Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice

Histone deacetylase (HDAC) inhibitors show remarkable therapeutic potential for a variety of disorders, including cancer, neurological disease, and cardiac hypertrophy. However, the specific HDAC isoforms that mediate their actions are unclear, as are the physiological and pathological functions of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Montgomery, Rusty L., Potthoff, Matthew J., Haberland, Michael, Qi, Xiaoxia, Matsuzaki, Satoshi, Humphries, Kenneth M., Richardson, James A., Bassel-Duby, Rhonda, Olson, Eric N.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2556240/
https://ncbi.nlm.nih.gov/pubmed/18830415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI35847
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars